Pharvaris (PHVS) Cash & Equivalents (2019 - 2026)
Pharvaris (PHVS) reported Cash & Equivalents of $369.96 million for Q2 2026, up 63.8% from $225.91 million a year earlier but down 100.0% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharvaris posted Cash & Equivalents of $329.54 million, up 8.5% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $303.84 million in FY2024 (-28.2%), $423.2 million in FY2023 (+91.8%), $220.65 million in FY2022 (-10.9%) and $247.75 million in FY2021 (+120.0%).
- Five-year quarterly Cash & Equivalents spans a low of $165.11 million in Q4 2022 and a high of $400.15 trillion in Q1 2024.
- Year over year, Cash & Equivalents gained in four of the last seven quarters, with growth averaging 0.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2021 (growth of 426.1%); the low point was Q1 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $289.13 trillion (Q1 2026), $339.53 million (Q4 2025) and $384.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Pharvaris | 2.22 Bn | 841.01 Mn | - | 363.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 363.54 Mn |
| Mar 31, 2026 | 283.01 Mn |
| Dec 31, 2025 | 342.64 Mn |
| Sep 30, 2025 | 386.30 Mn |
| Jun 30, 2025 | 234.05 Mn |
| Mar 31, 2025 | 255.98 Mn |
| Dec 31, 2024 | 292.13 Mn |
| Sep 30, 2024 | 340.90 Mn |
| Jun 30, 2024 | 367.92 Mn |
| Mar 31, 2024 | 397.61 Mn |
| Dec 31, 2023 | 433.02 Mn |
| Sep 30, 2023 | 167.27 Mn |
| Jun 30, 2023 | 194.74 Mn |
| Mar 31, 2023 | 147.41 Mn |
| Dec 31, 2022 | 172.53 Mn |
| Sep 30, 2022 | 194.36 Mn |
| Jun 30, 2022 | 210.38 Mn |
| Mar 31, 2022 | 217.40 Mn |
| Dec 31, 2021 | 237.09 Mn |
| Sep 30, 2021 | 253.61 Mn |
API Access
Pharvaris Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();